net acid excretion
Showing 1 - 25 of >10,000
Type 2 Diabetes Trial in Amsterdam (Empagliflozin 25 MG, Benzbromaron, Empagliflozin 25 MG + benzbromarone 100 mg)
Completed
- Type 2 Diabetes
- Empagliflozin 25 MG
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jan 13, 2022
Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)
Recruiting
- Gastroenteropancreatico Tumors
- +2 more
- Lu-177-DOTATATE
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)
Completed
- Neuroendocrine Tumors
- +3 more
- Amino Acid Based Medical Food/Drink
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 2, 2022
Aging, Well Aging Trial in Stuttgart (Placebo vegetable bouillon, microalgae phaeodactylum, From the Microalgae phaeodactylum
Recruiting
- Aging
- Well Aging
- Placebo vegetable bouillon
- +3 more
-
Stuttgart, Baden-Württemberg, GermanyStephan C. Bischoff, Prof. Dr
Jul 4, 2022
Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)
Active, not recruiting
- Kidney Diseases
- +4 more
- Low PRAL
-
Hillerød, DenmarkNordshjaellands Hospital
Jul 23, 2023
Chronic Kidney Diseases, Bone Loss Trial in Bronx (Potassium citrate, Placebo)
Not yet recruiting
- Chronic Kidney Diseases
- Bone Loss
- Potassium citrate
- Placebo
-
Bronx, New YorkAlbert Einstein College of Medicine
Jun 15, 2023
Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)
Recruiting
- Kidney Diseases
- +4 more
- Low PRAL
-
Hillerød, DenmarkNordshjaellands Hospital
Mar 27, 2023
Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension Trial (Fruits and vegetables (F+V), NaHCO3 Tablets, Usual Care)
Completed
- Chronic Kidney Diseases
- +2 more
- Fruits and vegetables (F+V)
- +2 more
- (no location specified)
Sep 18, 2023
Research and Development ofNew Technology for Detection of
Recruiting
- Gout
- +6 more
- no intervention
-
Hangzhou, Zhejiang, Chinathe second affliated hospital of Zhejiang university School of M
Jul 6, 2021
Healthy Adult Males Trial in Toronto (Crystalline amino acids to assess myofibrillar protein synthesis rates, Crystalline amino
Completed
- Healthy Adult Males
- Crystalline amino acids to assess myofibrillar protein synthesis rates
- Crystalline amino acids to assess whole-body protein turnover, amino acid oxidation, and net protein balance
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport at the University of
May 10, 2021
Early Screening and Diagnosis of CKD
Recruiting
- Kidney; Disease (Functional)
- Chronic Kidney Disease
- 99mTc-DTPA
-
Nanjing, Jiangsu, ChinaNanjing First Hospital, Nanjing Medical University
Apr 5, 2022
Kidney Stone Trial in Birmingham (Low Oxalate Diet, Carbon-13 Ascorbic Acid Oral Load)
Recruiting
- Kidney Stone
- Low Oxalate Diet
- Carbon-13 Ascorbic Acid Oral Load
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 15, 2022
Dietary Proteins Trial in Toronto (Milk Protein Concentrate, Rice Protein Isolate, Soy Protein Isolate)
Recruiting
- Dietary Proteins
- Milk Protein Concentrate
- +2 more
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport
Jan 18, 2022
Age-Related Sarcopenia, Muscle Loss Trial in Boston (whey protein isolate, potassium bicarbonate (KHCO3), microcrystalline
Recruiting
- Age-Related Sarcopenia
- Muscle Loss
- whey protein isolate
- +3 more
-
Boston, MassachusettsJean Mayer USDA Human Nutrition Research Center on Aging at Tuft
Apr 26, 2022
Increased Metabolic Requirement, Healthy Trial in Toronto (Amino Acid Intake)
Active, not recruiting
- Increased Metabolic Requirement
- Healthy
- Amino Acid Intake
-
Toronto, Ontario, CanadaGoldring Centre for High Performance Sport
Jan 18, 2022
Secretin in Refeeding
Not yet recruiting
- Anorexia in Adolescence
- (no location specified)
Feb 1, 2022
Cystic Fibrosis (CF), CFTR Gene Mutation Trial (12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause)
Not yet recruiting
- Cystic Fibrosis (CF)
- CFTR Gene Mutation
- 12 hours ETI pause
- +2 more
- (no location specified)
Apr 17, 2023
Aluminium Overload, Biological Availability Trial in Guadalupe, Reus (ORGONO Living Silica Acacia Gum-MMST Powder, ORGONO Living
Completed
- Aluminium Overload
- Biological Availability
- ORGONO Living Silica Acacia Gum-MMST Powder
- +3 more
-
Guadalupe, Murcia, Spain
- +1 more
Sep 15, 2022
Dietary Proteins, Indicator Amino Acid Oxidation Trial in Toronto (2% milk beverage, Almond milk alternative beverage, Soy milk
Recruiting
- Dietary Proteins
- Indicator Amino Acid Oxidation
- 2% milk beverage
- +3 more
-
Toronto, Ontario, CanadaGoldring Centre for High Performance and Sport
Apr 11, 2023
Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)
Completed
- Diabetes Mellitus
- Sotagliflozin (SAR439954)
- Mefenamic acid
-
Gières, FranceInvestigational site 250001
Apr 21, 2022
Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)
Completed
- Neuroendocrine Tumors
-
Innsbruck, AustriaDepartment of Nuclear Medicine, Medical University of Innsbruck
Nov 24, 2023
Healthy Lactating Women Trial in Las Vegas (Bempedoic Acid 180 MG Oral Tablet, Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral
Recruiting
- Healthy Lactating Women
- Bempedoic Acid 180 MG Oral Tablet
- Bempedoic Acid/Ezetimibe 180 MG-10 MG Oral Tablet
-
Las Vegas, NevadaPPD Development, Las Vegas Research Unit
Aug 27, 2023
Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE
Not yet recruiting
- Bronchial and Thymic Neuroendocrine Tumour
- +3 more
- Lu-177 DOTATATE (Lutathera®)
- (no location specified)
Nov 1, 2023
Hyperuricemia Trial in Jinhua (Study Product A (High-dose 2X), Study Product B (Low-dose X), Placebo)
Recruiting
- Hyperuricemia
- Study Product A (High-dose 2X)
- +2 more
-
Jinhua, Zhejiang, ChinaCharlie Zhang
Oct 10, 2023